The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh
Open Access
- 3 December 2016
- journal article
- research article
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 14 (1) , 1-10
Abstract
Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) that include limited stakeholder awareness, resources and data availability, as well as the lack of capacity to conduct country-specific economic evaluations. This study aims to survey health policy experts’ opinions on barriers to use of cost-effectiveness data in these settings and to obtain their advice on how to make a new cost-per-DALY database being developed by Tufts Medical Center more relevant to LMICs. It also identifies the factors influencing transferability. In-depth interviews were conducted with 32 participants, including policymakers, technical advisors, and researchers in Health Ministries, universities and non-governmental organisations in Bangladesh, India (New Delhi, Tamil Nadu and Karnataka) and Vietnam. The survey revealed that, in all settings, the use of cost-effectiveness information in policy development is lacking, owing to limited knowledge among policymakers and inadequate human resources with health economics expertise in the government sector. Furthermore, researchers in universities do not have close connections with health authorities. In India and Vietnam, the demand for evidence to inform coverage decisions tends to increase as the countries are moving towards universal health coverage. The informants in all countries argue that cost-effectiveness data are useful for decision-makers; however, most of them do not perform data searches by themselves but rely on the information provided by the technical advisor counterparts. Most interviewees were familiar with using evidence from other countries and were also aware of the influences of contextual elements as a limitation of transferability. Finally, strategies to promote the newly developed database include training on basic economic evaluation for policymakers and researchers, and effective communication programs, with support from reputable global agencies. Although cost-effectiveness information is recognised as essential in resource allocation, there are several impediments in the generation and use of such evidence to inform priority setting in LMICs. As such, the Cost-per-DALY database should be well-designed and introduced with appropriate promotion strategies so that it will be helpful in real-world policymaking.Keywords
Funding Information
- Bill and Melinda Gates Foundation
This publication has 23 references indexed in Scilit:
- A systematic review of coverage decision-making on health technologies—Evidence from the real worldHealth Policy, 2012
- A Bibliometric Review of Cost-Effectiveness Analyses in the Economic and Medical Literature: 1976-2006Medical Decision Making, 2010
- The Current Capacity and Future Development of Economic Evaluation for Policy Decision-Making: A Survey among Researchers and Decision-Makers in ThailandValue in Health, 2009
- Using Economic Evaluation in Policy Decision-Making in Asian Countries: Mission Impossible or Mission Probable?Value in Health, 2009
- Adjusting life for quality or disability: stylistic difference or substantial dispute?Health Economics, 2008
- A systematic review of the use of economic evaluation in local decision-makingHealth Policy, 2008
- Calculating QALYs, comparing QALY and DALY calculationsHealth Policy and Planning, 2006
- Health-care decision-making processes in Latin America: Problems and prospects for the use of economic evaluationInternational Journal of Technology Assessment in Health Care, 2005
- Priority setting for pharmaceuticalsThe European Journal of Health Economics, 2004
- The influence of economic evaluation studies on decision making.Health Policy, 2000